Cordblood-Based High-Throughput Screening for Deafness Gene of 646 Newborns in Jinan Area of China
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives. Infants with slight/mild or late-onset hearing impairment might be missed in universal newborn hearing screening (UNHS). We identified the mutation hot spot of common deaf gene in the newborns in Jinan area population by screening the mutation spot with neonate cord blood, in order to make clear whether the neonate cord blood for screening is feasible. Methods. Six hundred and forty-six newborns were subjected to both UNHS and genetic screening for deafness by using neonate cord blood. The newborn genetic screening targeted four deafness-associated genes, which were commonly found in the Chinese population including gap junction beta-2 protein (GJB2), gap junction beta-3 protein (GJB3), solute carrier family 26 member 4 (SLC26A4), and mtDNA 12S rRNA. The most common 20 spot mutations in 4 deaf genes were detected by MassARRAY iPLEX platform and mitochondrial 12S rRNA A1555G and C1494T mutations were sequenced using Sanger sequencing. Results. Among the 646 newborns, 635 cases passed the UNHS and the other 11 cases (1.7%) did not. Of the 11 failures, two cases were found to carry homozygous GJB2 p.R143W pathogenic mutation, one case was found to have heterozygous GJB2 235delC mutation, and another one case carried heterozygous GJB3 p.R180X pathogenic mutation. Six hundred and thirty-five babies passed the newborn hearing screening, in which 25 babies were identified to carry pathogenic mutations, including 12 heterozygotes (1.9%) for GJB2 235delC, eight heterozygotes (1.3%) for SLC26A4 IVS7-2A>G, one heterozygote (0.2%) for p.R409H, two homozygotes (0.3%) for m.1494C>T, and two homozygotes (0.3%) for m.1555A>G. Conclusion. Newborn genetic screening through the umbilical cord blood for common deafness-associated mutations may identify carriers sensitive to aminoglycoside antibiotic, and can effectively prevent or delay hearing loss occurs.
Abstract
Objectives. Infants with slight/mild or late-onset hearing impairment might be missed in universal newborn hearing screening (UNHS). We identified the mutation hot spot of common deaf gene in the newborns in Jinan area population by screening the mutation spot with neonate cord blood, in order to make clear whether the neonate cord blood for screening is feasible. Methods. Six hundred and forty-six newborns were subjected to both UNHS and genetic screening for deafness by using neonate cord blood. The newborn genetic screening targeted four deafness-associated genes, which were commonly found in the Chinese population including gap junction beta-2 protein (GJB2), gap junction beta-3 protein (GJB3), solute carrier family 26 member 4 (SLC26A4), and mtDNA 12S rRNA. The most common 20 spot mutations in 4 deaf genes were detected by MassARRAY iPLEX platform and mitochondrial 12S rRNA A1555G and C1494T mutations were sequenced using Sanger sequencing. Results. Among the 646 newborns, 635 cases passed the UNHS and the other 11 cases (1.7%) did not. Of the 11 failures, two cases were found to carry homozygous GJB2 p.R143W pathogenic mutation, one case was found to have heterozygous GJB2 235delC mutation, and another one case carried heterozygous GJB3 p.R180X pathogenic mutation. Six hundred and thirty-five babies passed the newborn hearing screening, in which 25 babies were identified to carry pathogenic mutations, including 12 heterozygotes (1.9%) for GJB2 235delC, eight heterozygotes (1.3%) for SLC26A4 IVS7-2A>G, one heterozygote (0.2%) for p.R409H, two homozygotes (0.3%) for m.1494C>T, and two homozygotes (0.3%) for m.1555A>G. Conclusion. Newborn genetic screening through the umbilical cord blood for common deafness-associated mutations may identify carriers sensitive to aminoglycoside antibiotic, and can effectively prevent or delay hearing loss occurs.
참고문헌 (28)
- Ouyang XM, "The genetic bases for non-syndromic hearing loss among Chinese", J Hum Genet, 54(3), pp.131~140 (2009)
- Propst EJ, "Ethnicity and mutations in GJB2 (connexin 26) and GJB6 (connexin 30) in a multi-cultural Canadian paediatric Cochlear Implant Program", Int J Pediatr Otorhinolaryngol, 70(3), pp.435~444 (2006)
- Snoeckx RL, "GJB2 mutations and degree of hearing loss: a multicenter study", Am J Hum Genet, 77(6), pp.945~957 (2005)
- Wang QJ, "A distinct spectrum of SLC26A4 mutations in patients with enlarged vestibular aqueduct in China", Clin Genet, 72(3), pp.245~254 (2007)
- Kokotas H, "Mitochondrial deafness", Clin Genet, 71(5), pp.379~391 (2007)
- Kennedy C, "Universal neonatal hearing screening moving from evidence to practice", Arch Dis Child Fetal Neonatal Ed, 89(5), pp.F378~F383 (2004)
- Johnson JL, "multicenter evaluation of how many infants with permanent hearing loss pass a two-stage otoacoustic emissions", automated auditory brainstem response newborn hearing screening protocol, 2005, pp.116(3), 663~672
- Yoshinaga-Itano C, "Language of early- and later-identified children with hearing loss", Pediatrics, 102(5), pp.1161~1171 (1998)
- Brobby GW, "Connexin 26 R143W mutation associated with recessive nonsyndromic sensorineural deafness in Africa", N Engl J Med, 338(8), pp.548~550 (1998)
- Li L, "The p.V37I exclusive genotype of GJB2: a genetic risk-indicator of postnatal permanent childhood hearing impairment", PLoS One, 7(5), pp.e36621~ (2012)
- Oh SK, "Evaluation of the pathogenicity of GJB3 and GJB6 variants associated with nonsyndromic hearing loss", Biochim Biophys Acta, 1832(1), pp.285~291 (2013)
- Jackler RK, "The large vestibular aqueduct syndrome", Laryngoscope, 99(12), pp.1238~1242 (1989)
- Reardon W, "Enlarged vestibular aqueduct: a radiological marker of pendred syndrome, and mutation of the PDS gene", QJM, 93(2), pp.99~104 (2000)
- Pryor SP, "SLC26A4", PDS genotype-phenotype correlation in hearing loss with enlargement of the vestibular aqueduct (EVA): evidence that Pendred syndrome and non-syndromic EVA are distinct clinical and genetic entities, 2005, pp.42(2), 159~165
- Lu J, "Mitochondrial 12S rRNA variants in 1642 Han Chinese pediatric subjects with aminoglycoside-induced and nonsyndromic hearing loss", Mitochondrion, 10(4), pp.380~390 (2010)
- Nivoloni Kde A, "Newborn hearing screening and genetic testing in 8974 Brazilian neonates", Int J Pediatr Otorhinolaryngol, 74(8), pp.926~929 (2010)
- Wu CC, "Newborn genetic screening for hearing impairment: a preliminary study at a tertiary center", PLoS One, 6(7), pp.e22314~ (2011)
- Guan MX., "Mitochondrial 12S rRNA mutations associated with aminoglycoside ototoxicity", Mitochondrion, 11(2), pp.237~245 (2011)
- Zhao H, "Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family", Am J Hum Genet, 74(1), pp.139~152 (2004)
- Lu J, "Mitochondrial haplotypes may modulate the phenotypic manifestation of the deafness-associated 12S rRNA 1555A>G mutation", Mitochondrion, 10(1), pp.69~81 (2010)
- Schimmenti LA, "Infant hearing loss and connexin testing in a diverse population", Genet Med, 10(7), pp.517~524 (2008)
- Norris VW, "Does universal newborn hearing screening identify all children with GJB2 (Connexin 26) deafness? Penetrance of GJB2 deafness", Ear Hear, 27(6), pp.732~741 (2006)
- Young NM, "Limitations of universal newborn hearing screening in early identification of pediatric cochlear implant candidates", Arch Otolaryngol Head Neck Surg, 137(3), pp.230~234 (2011)
- Pollak A, "M34T and V37I mutations in GJB2 associated hearing impairment: evidence for pathogenicity and reduced penetrance", Am J Med Genet A, 143(21), pp.2534~2543 (2007)
- Park HJ, "Origins and frequencies of SLC26A4 (PDS) mutations in east and south Asians: global implications for the epidemiology of deafness", J Med Genet, 40(4), pp.242~248 (2003)
- Miyagawa M, "Deafness Gene Study Consortium. Mutation spectrum and genotype-phenotype correlation of hearing loss patients caused by SLC26A4 mutations in the Japanese: a large cohort study", J Hum Genet, 59(5), pp.262~268 (2014)
- Choi BY, "Hypo-functional SLC26A4 variants associated with nonsyndromic hearing loss and enlargement of the vestibular aqueduct: genotype-phenotype correlation or coincidental polymorphisms?", Hum Mutat, 30(4), pp.599~608 (2009)
- Yuan Y, "Common molecular etiologies are rare in nonsyndromic Tibetan Chinese patients with hearing impairment", PLoS One, 7(2), pp.e30720~ (2012)
